X-linked Hypophosphatemia: Burosumab (Crysvita) to the rescue

 December 16, 2017 – As recent as of December 14, 2017, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the granting of a conditional marketing authorisation for the medicinal product Burosumab (Crysvita), intended for the treatment of X-linked hypophosphataemia. Burosumab (Crysvita) was designated as an orphan medicinal product on October 15, 2014.

X-linked. Father is not like mother

X-linked hypophosphatemia (XLH), also called X-linked dominant hypophosphatemic rickets, X-linked vitamin d-resistant rickets, is an X-linked dominant form of rickets (or osteomalacia) that differs from most cases of rickets in that ingestion of vitamin D is relatively ineffective. It can cause bone deformity including short stature and genu varum (bow leggedness). It is associated with a mutation in the PHEX gene sequence (Xp.22) and subsequent inactivity of the PHEX protein. The prevalence of the disease is 1 in 20’000 persons.

Burosumab (Crysvita) will be available as a solution for injection (10 mg/ml, 20 mg/ml and 30 mg/ml). The active substance of Crysvita is burosumab, a human monoclonal antibody that binds to and inhibits the activity of fibroblast growth factor 23 (FGF23). Inhibiting the activity of elevated serum fibroblast growth factor 23 in X-linked hypophosphataemia reduces the loss of phosphate from the kidney and other metabolic abnormalities, which are considered to be causative of the disease’s bone changes.

The benefits with Burosumab (Crysvita) are its ability to reduce the loss of phosphate from the kidney, to improve abnormally low serum

X-linked. Mother is not like father.

phosphate concentrations and to reduce the severity of rickets as shown in x-rays. The most common side effects are injection site reactions, headache, and pain in extremities. The full indication is: “Burosumab (Crysvita) is indicated for the treatment of X-linked hypophosphataemia with radiographic evidence of bone disease in children 1 year of age and older and adolescents with growing skeletons.” It is proposed that Burosumab (Crysvita) be prescribed by physicians experienced in the management of patients with metabolic bone diseases.

Detailed recommendations for the use of this product will be described in the summary of product characteristics (SmPC), which will be published in the European public assessment report (EPAR) and made available in all official European Union languages after the marketing authorisation has been granted by the European Commission.


Note that a conditional marketing authorisation is granted to a medicinal product that fulfils an unmet medical need when the benefit to public health of immediate availability outweighs the risk inherent in the fact that additional data are still required. The marketing authorisation holder is likely to provide comprehensive clinical data at a later stage.

Tags: , , , , , , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.
14 comments on “X-linked Hypophosphatemia: Burosumab (Crysvita) to the rescue
  1. Highly descriptive article, I loved that a lot. Will there be a part 2?

  2. minecraft says:

    Wonderful, what a webpage it is! This webpage presents valuable data to us, keep it up.

  3. minecraft says:

    Hi, i read your blog from time to time and i own a similar one and i was just wondering if you
    get a lot of spam responses? If so how do you stop it, any plugin or anything you
    can advise? I get so much lately it’s driving me insane so any assistance is very much appreciated.

  4. minecraft says:

    Thanks for finally talking about >X-linked Hypophosphatemia: Burosumab (Crysvita) to the rescue | thasso <Liked it!

  5. minecraft says:

    Oh my goodness! Incredible article dude! Thank you so much, However I am encountering
    problems with your RSS. I don’t understand why I
    cannot join it. Is there anybody else getting similar RSS problems?
    Anyone that knows the answer can you kindly respond?
    Thanks!!

  6. minecraft says:

    I’m not that much of a internet reader to be honest but your sites really
    nice, keep it up! I’ll go ahead and bookmark your website to come back later
    on. All the best

  7. minecraft says:

    Thanks designed for sharing such a good idea, post is good, thats why i have read it completely

  8. minecraft says:

    Very good post! We are linking to this great post on our website.
    Keep up the great writing.

  9. Just desire to say your article is as amazing. The clarity to
    your post is simply spectacular and i could suppose you
    are an expert in this subject. Fine with your permission let me to clutch
    your RSS feed to keep updated with coming near near post.
    Thanks 1,000,000 and please continue the rewarding work.

  10. Its such as you learn my thoughts! You appear to grasp
    a lot approximately this, such as you wrote the guide in it or something.

    I think that you just could do with a few percent to pressure
    the message house a bit, however other than that,
    that is excellent blog. An excellent read. I will certainly be back.

  11. NarcosXXX says:

    Hey There. I discovered your blog the use of msn. This is an extremely
    smartly written article. I’ll make sure to bookmark it and come back to learn more of your useful
    information. Thank you for the post. I’ll definitely comeback.

  12. I think that what you posted was actually very reasonable.
    But, what about this? what if you added a little content?
    I mean, I don’t want to tell you how to run your
    blog, but what if you added a title that makes people desire more?

    I mean X-linked Hypophosphatemia: Burosumab (Crysvita) to the rescue
    | thasso is kinda plain. You could glance at Yahoo’s home page and watch how they create news titles to grab viewers to click.

    You might add a video or a picture or two to get people excited about what you’ve written.
    In my opinion, it might bring your posts a little
    livelier.

  13. Good one! Amazing article over here. It is pretty worth enough for me. From my point of view, if all web owners and bloggers made good content as you did, the web will be much more helpful than ever before. I could not refrain from commenting. I ‘ve spent some time trying to find such infos. I’ll also share it with a couple of friends interested in it. I’ve just bookmarked this web. Finished with the job done, I going to find some free online model Webcams. Thank you very much!! Greetings from Norwalk!

Leave a Reply

Optional: Social Subscribe/Login




Your email address will not be published. Required fields are marked *

*

thasso: community

thasso: conditions

thasso post: magazine

View my Flipboard Magazine.

thasso: follow us

thasso: chat

You must be a registered user to participate in this chat.

thasso: tweets

thasso: categories

thasso: archives

Top